Skip Links

 
 

Terms and conditions

Privacy policy

Hikma Pharmaceuticals PLC and its group of companies (”Hikma”) may use your name and contact details to send you press releases, events alerts and other information that may be of interest to you. Hikma may also pass these contact details to relevant third parties in countries including Jordan and the United States of America to enable them to disseminate information. Those countries may provide lower standards of data protection than your home country.

By submitting your name and contact details, you agree that they may be used in these ways.

If you have any queries concerning the use of your name or contact details, please contact Hikma Pharmaceuticals PLC, 13 Hanover Square, London W1S 1HL, United Kingdom, Tel:+44 (0)20 7399 2760.

Products disclaimer

Hikma Pharmaceuticals PLC and its group of companies (”Hikma”) may use name and contact details of registered users to send press releases, events alerts and other information that may be of interest to them. Hikma may also pass these contact details to relevant third parties in countries including Jordan and the United States of America to enable them to dissseminate information. Those countries may provide lower standards of data protection than your home country.

By submitting their name and contact details, registered users agree that they may be used in these ways.

Any queries concerning the use of registered users’ names or contact details should be directed to Hikma Pharmaceuticals PLC, 13 Hanover Square, London W1S 1HL, United Kingdom, Tel: +44 (0)20 7399 2760.

Share price disclaimer

The share price details are given for information purposes only and nothing on this web site constitutes an invitation or offer to invest or deal in the shares, or any other securities, of Hikma Pharmaceuticals plc. Actual results and performance may differ materially from any forecast, opinion or expectation, including any expressed on this web site, and the past performance of securities is no guide to their future performance.

Share price

24 Jul 2008

406.25p (-2.69%)